![Dirk Huebner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Huebner
Teknisk/Vetenskaplig/F&U Direktör på
APTEVO THERAPEUTICS INC.
Förmögenhet: 1 981 $ per 2026-07-31
Profil
Dirk Huebner is Chief Medical Officer & Senior Vice President at Aptevo Therapeutics, Inc. since 2025.
Formerly, Dr. Huebner was Executive Medical Director at Millennium Pharmaceuticals, Inc. in 2017, Chief Medical Officer at Mersana Therapeutics, Inc. from 2018 to 2020, and Vice President at Boston Biomedical, Inc. from 2017 to 2018.
Education includes a doctorate from Freie Universität Berlin.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-06 | 482 ( 0,04 % ) | 1 981 $ | 2026-07-31 |
Aktiva positioner av Dirk Huebner
| Företag | Position | Start |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-04-01 |
Tidigare kända positioner av Dirk Huebner
| Företag | Position | Slut |
|---|---|---|
| MERSANA THERAPEUTICS | Teknisk/Vetenskaplig/F&U Direktör | 2020-11-30 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Företagsledare/Principal | 2018-11-01 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Företagsledare/Principal | 2017-08-01 |
Dirk Huebners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
46
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Commercial Services |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
